Results 161 to 170 of about 328,528 (303)

Fair Generalized Linear Models with a Convex Penalty. [PDF]

open access: yesProc Mach Learn Res, 2022
Do H   +4 more
europepmc   +1 more source

Review of Generalized Latent Variable Modeling by Skrondal and Rabe-Hesketh [PDF]

open access: yes
The new book by Skrondal and Rabe-Hesketh (2004) is reviewed.GLLAMM, generalized linear latent and mixed models, latent ...
Roger Newson
core   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni   +19 more
wiley   +1 more source

Effect Displays in R for Multinomial and Proportional-Odds Logit Models: Extensions to the effects Package [PDF]

open access: yes
Based on recent work by Fox and Andersen (2006), this paper describes substantial extensions to the effects package for R to construct effect displays for multinomial and proportional-odds logit models.
Jangman Hong, John Fox
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy